Hims & Hers Health Inc. was put on notice by Visa Inc. for excessive customer complaints in its weight-loss subscription business, internal documents show. This situation adds to mounting scrutiny of its billing and cancellation policies.
Hims & Hers Health Inc. plans to jump into the peptides market before the end of the year, with executives seeing opportunity to seize on a booming corner of the health industry.
Hims & Hers Health shares are down after the telehealth firm reduced the top end of its adjusted Ebitda forecast for the full year.
Telehealth companies including Hims & Hers and Noom have called on a panel of experts to recommend the legalization of several popular peptides. They emphasized the need for increased oversight and the establishment of a system to report side effects.